课题基金 / 基金详情

Study on the Pathogenesis of Type 1 Diabetes Mellitus

Study on the Pathogenesis of Type 1 Diabetes Mellitus
1型糖尿病发病机制研究
批准号:
01480290
负责人:
HANAFUSA Toshiaki
金额:
$4.29万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990

项目摘要

项目成果

HANAFUSA Toshiaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The pathogenic role of abnormal expression of major histocompatibility complex (MHC) antigens on pancreatic beta cells was studied using molecular biological techniques.We first tested which cytokines could induce MHC antigen expression on rat insulinoma cell line RINm5F. Messenger RNAs of class I and class II MHC molecules were examined by Northern analysis. The result showed that, in the absence of cytokines, 1) class I MHC antigen mRNA was constitutively expressed but 2) class II MHC mRNA was not detected in RINm5F cells. Class I mRNA was increased in response to either interferonーgamma (IFNgamma) or IFNgamma plus tumor necrosis factorーalpha (TNFalpha). However, no class II mRNA was detected after the challenge of any cytokines. On the other hand, insulin mRNA was decreased in the presence of either IFNgamma or IFNgamma+TNFalpha.We secondly examined the effect of MHC antigen expression on beta cell function, namely insulin secreting capacity. RINm5F cells were transfected with human MHC class I antigen (HLA-Cw2) gene and twelve clones with different degrees of expression of the transfectant were obtained. Insulin secreting capacity of the clones in response to glucose was negatively correlated with the amount of class I MHC antigen expressed.These results indicate that the expression of MHC antigen in beta cells is controlled by various cytokines and that insulin secreting capacity is impaired by the expression of MHC antigens in beta cells. This suggests the importance of MHC antigen expression in the pathogenesis of Type 1 diabetes mellitus.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
T.Hanafusa,et al.: "Examination of islets in the pancreas biopsy specimens from newly diagnosed Type 1 (insulinーdependent) diabetic patients." Diabetologia. 33. 105-111 (1990)
T.Hanafusa 等人:“对新诊断的 1 型(胰岛素依赖型)糖尿病患者的胰腺活检标本中的胰岛进行检查。” 33. 105-111 (1990)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Yamagata,et al.: "HLAーDQ1^*1 contributes to resistance and A1^*3 confers susceptiーbility to Type 1 diabetes mellitus in Japanese subjects." Diabetologia. (1991)
K. Yamagata 等人:“HLA-DQ1^*1 有助于日本受试者抵抗,而 A1^*3 则增加对 1 型糖尿病的易感性”(1991)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A.Miyazaki,et al.: "Demonstration of interleukin-1β on perifollicular endothelial cells in the thyroid glands of patients with Graves' disease." J.Clin.Endocrinol.Metab.69. 738-744 (1989)
A. Miyazaki 等人:“Graves 病患者甲状腺滤泡周围内皮细胞中白细胞介素 1β 的表现。J.Clin.Endocrinol.Metab.69 (1989)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
26
    Research on the pathogenesis of fulminant type 1 diabetes - investigation of quantitative and qualitative abnormalities of regulatory T cell -
    • 批准号:
      24591345
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2012
    • 负责人:
      HANAFUSA Toshiaki
    • 依托单位:
    Development of the treatment for fulminant type1 diabetes using the model mouse
    • 批准号:
      21591149
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      HANAFUSA Toshiaki
    • 依托单位:
    Etiology of fulminant type 1 diabetes -analysis of the pancreas tissues
    • 批准号:
      19591069
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2007
    • 负责人:
      HANAFUSA Toshiaki
    • 依托单位:
    Etiology of fulminant type 1 diabetes with reference to enteroviral infection
    • 批准号:
      16590896
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2004
    • 负责人:
      HANAFUSA Toshiaki
    • 依托单位:
    海外基金